• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Severe Anemia Is Associated with Necrotizing Enterocolitis, not RBC Transfusions

March 9, 2016

small premature baby lies in an incubator a grown hand reaches in grasping the foot in caring manner

Necrotizing enterocolitis is the leading cause of mortality in preterm infants.  Although there is conflicting evidence, red blood cell (RBC) transfusions and/or anemia may be risk factors for necrotizing enterocolitis.

Since transfusions are often used to treat anemia, researchers evaluated RBC transfusions and anemia in 598 very low-birth-weight (VLBW) infants at risk for necrotizing enterocolitis in three Atlanta hospitals.  Forty-four (7.4%) infants were diagnosed with necrotizing enterocolitis, and 32 (5.4%) died (all causes).  Slightly over half (N = 319, 53%) of the infants received RBC transfusions; however, transfusions were not significantly associated with a risk of necrotizing enterocolitis (adjusted hazard ratio=0.44 [95% CI, 0.17-1.12]).  The rate of  necrotizing enterocolitis among VLBW infants with severe anemia (hemoglobin < 8 g/dL) was significantly higher than those who did not have severe anemia (adjusted hazard ratio, 5.99 [95% CI, 2.00-18.00]).  Further studies are needed to assess the risk of necrotizing enterocolitis in preterm infants with severe anemia.

 

 

Reference

  1. Patel RM, Knezevic A, Shenvi N, Hinkes M, Keene S, Roback JD, Easley KA, Josephson CD. Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016;315: 889-97.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • COVID-19 Convalescent Plasma Reduces Mortality for Patients with Acute Respiratory Distress Syndrome

  • Pathogen Reduction Technology Safe and Effective for Red Blood Cell Transfusions in Pediatric Patients with Cancer

  • Stored Whole Blood Treated with Pathogen Reduction Acceptable for Transfusion

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

  • Transfusion-related Alpha-Gal Syndrome

  • 2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

  • Machine Learning Model for Estimating Perioperative Transfusion Risks

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley